June 22nd 2025, 6:00pm
Combining JNJ-1900 with Keytruda may improve distant control of lung cancer, explained by Dr. Jared Weiss.
June 22nd 2025, 2:00pm
The 2025 ASCO Annual Meeting brought many different updates to light in the realm of hematological malignancies, including multiple myeloma and lymphoma.
June 21st 2025, 6:00pm
Dr. Michael Serzan emphasizes the importance of clinical trial participation for patients with kidney cancer.
June 21st 2025, 2:00pm
Patients with blood cancers like polycythemia vera, a kind of myeloproliferative neoplasm, may benefit in learning more about recent data from ASCO 2025.
June 20th 2025, 9:00pm
It’s a bad day when a doctor says you have cancer. It’s a worse day when he says it’s stage prostate cancer with a metastatic lesion.
June 20th 2025, 7:00pm
Trials enrolling patients with relapsed leukemia, lymphoma and brain cancers, respectively, report early data showing safety/activity with novel therapies.
June 20th 2025, 5:00pm
Surviving cancer wasn’t the end of my story; it was the start of redefining life, finding purpose and offering hope to those walking behind me.
June 20th 2025, 4:00pm
Dr. Prantesh Jain and Dr. Joshua Sabari delved into the numerous advances in NSCLC following 2025 ASCO, highlighting the REZILIENT-1 and NeoADAURA trials.
June 20th 2025, 3:00pm
Dr. Breelyn Wilky explains that personalized treatments are helping improve outcomes for patients with gastrointestinal stromal tumors.
June 20th 2025, 1:00pm
Dr. Rita Mukhtar and Dr. Joshua K. Sabari discuss the role of ctDNA to guide surgical decision-making after neoadjuvant chemo in breast cancer treatment.
Understanding Thymoma Cancer and Its Treatment Options: A Patient Guide
Understanding Your Diagnosis: Stage 2 Oral Cavity Cancer
Understanding Your Diagnosis of Bile Duct Cancer
Understanding Your Stage 2 Uterine (Endometrial) Cancer